Home/Investors/Venture capital details not widely publicized

Venture capital details not widely publicized

Biotech Investor · 4 portfolio companies

Portfolio
4
Focus Areas
3
Top Stage
preclinical

Portfolio Companies

CompanyValuation
AllinkBio
Amphiprotech
Alpha Biopharma (2)
Acerand Therapeutics